Cellect Biotechnology Ltd ADR (APOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APOP | AZN | AMGN | GILD | BMY |
| Company | Cellect Biotechnology Ltd ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 13.12 | 186.69 | 336.26 | 133.77 | 56.69 |
| High | 13.37 | 186.70 | 337.94 | 134.65 | 57.05 |
| Low | 13.10 | 184.70 | 333.47 | 132.69 | 56.10 |
| Latest | 13.17 | 185.51 | 337.00 | 133.18 | 56.85 |
| Change | +0.05 | -2.21 | +0.55 | +0.13 | +0.46 |
| % Change | +0.38% | -1.18% | +0.16% | +0.10% | +0.82% |
| Volume | 17,400 | 254,330 | 325,543 | 594,247 | 1,129,578 |
| 20-Day Average Volume | 111,620 | 2,023,071 | 2,603,352 | 6,059,470 | 9,843,447 |
| Previous Close | 13.12 | 187.72 | 336.45 | 133.05 | 56.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.78 | 188.22 | 338.39 | 132.77 | 57.81 |
| 20-Day Raw Stochastic | 9.22% | 22.23% | 44.91% | 52.44% | 25.77% |
| 20-Day Relative Strength | 36.80 | 44.43 | 45.71 | 47.34 | 45.64 |
| Weighted Alpha | -3.21 | +28.15 | +19.13 | +25.54 | +21.38 |
| Today's Opinion | 24% Sell | 16% Sell | 24% Sell | 24% Buy | 8% Buy |
| Previous Opinion | 24% Sell | 8% Buy | 24% Sell | 24% Buy | 16% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 24% Buy | 56% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.80% since 10/21/21 | +1.70% since 05/07/26 | +2.36% since 05/07/26 | -0.05% since 05/07/26 | +0.96% since 05/07/26 |
| Low | 12.55 on 10/26/21 | 181.58 on 05/08/26 | 327.62 on 05/11/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 14.00 on 10/22/21 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.04 on 05/14/26 |
| 1-Month | |||||
| %Chg | -28.77% since 09/28/21 | -9.18% since 04/14/26 | -4.01% since 04/14/26 | -4.60% since 04/14/26 | -2.22% since 04/14/26 |
| Low | 12.55 on 10/26/21 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 19.44 on 09/30/21 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.96 on 04/15/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -19.89% since 07/28/21 | -9.69% since 02/13/26 | -8.76% since 02/13/26 | -13.54% since 02/13/26 | -6.50% since 02/13/26 |
| Low | 12.55 on 10/26/21 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 35.52 on 09/03/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +27.12% since 04/28/21 | +4.17% since 11/14/25 | +0.04% since 11/14/25 | +7.18% since 11/14/25 | +21.74% since 11/14/25 |
| Low | 9.28 on 05/06/21 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 35.52 on 09/03/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,872 | 291,136,448 | 181,577,024 | 165,190,896 | 115,152,384 |
| Shares Outstanding, K | 977 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -5,620,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -5,579,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.87 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/24/21 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 11/19/21 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.93 | 15.22 | 16.12 | 9.52 |